Aloe vera in the treatment for oral submucous fibrosis - a preliminary study

J Oral Pathol Med (2012) 41: 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oral pathology & medicine Vol. 41; no. 10; pp. 755 - 761
Main Authors: Sudarshan, Ramachandran, Annigeri, Rajeshwari G., Sree Vijayabala, G.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-11-2012
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract J Oral Pathol Med (2012) 41: 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Methods:  Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘t’ test and unpaired ‘t’ test. Results:  Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group. Interpretation and conclusion:  Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF.
AbstractList J Oral Pathol Med (2012) 41 : 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Methods:  Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘ t ’ test and unpaired ‘ t ’ test. Results:  Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation ( P  = 0.008), improvement in mouth opening ( P  = 0.02), and cheek flexibility ( P  = 0.01) on comparing with the antioxidant group. Interpretation and conclusion:  Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF.
Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired 't' test and unpaired 't' test. Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild-stage clinically and early-stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group. Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients' compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF.
BACKGROUND AND OBJECTIVESOral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF.METHODSTwenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired 't' test and unpaired 't' test.RESULTSAloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild-stage clinically and early-stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group.INTERPRETATION AND CONCLUSIONOverall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients' compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF.
J Oral Pathol Med (2012) 41: 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Methods:  Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘t’ test and unpaired ‘t’ test. Results:  Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group. Interpretation and conclusion:  Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF.
Author Sudarshan, Ramachandran
Annigeri, Rajeshwari G.
Sree Vijayabala, G.
Author_xml – sequence: 1
  givenname: Ramachandran
  surname: Sudarshan
  fullname: Sudarshan, Ramachandran
  organization: Department of Oral Medicine and Radiology, Sibar Institute of Dental Sciences, Guntur, Andhra Pradesh, India
– sequence: 2
  givenname: Rajeshwari G.
  surname: Annigeri
  fullname: Annigeri, Rajeshwari G.
  organization: Department of Oral Medicine and Radiology, College of Dental Sciences & Hospital, Davangere, Karnataka, India
– sequence: 3
  givenname: G.
  surname: Sree Vijayabala
  fullname: Sree Vijayabala, G.
  organization: Department of Oral Medicine and Radiology, Thai Moogambikai Dental College and Hospital, Chennai, India
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26581304$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22650317$$D View this record in MEDLINE/PubMed
BookMark eNqNkMtu1DAYhS1URKctr4C8QWKT1JfYThYsSqcXqlHbBYil5Ti_hYdcBjuBmbevwwzDFm9syd_xf_ydoZN-6AEhTElO07pc51QSkhFFi5wRynJCqSzz7Su0OF6coAWpSJExQdkpOotxTQhVvKBv0CljUhBO1QKtrtoB8C8IBvsej98BjwHM2EE_YjcEPATT4jjV3WSHKWLn6zBEH3GGDd4EaH3nexN2OI5Ts7tAr51pI7w97Ofo6-3Nl-v7bPV09_n6apXZgqsys5VghJWSNU1lBS-NAMfAFg2U1tU1LYFzxoSkdaOc5cw0RQlgnVOyASY4P0cf9u9uwvBzgjjqzkcLbWt6SC01pbySrBAVS2i5R23qHQM4vQm-S401JXp2qdd6VqZnZXp2qf-41NsUfXeYkr4PzTH4V14C3h8AE61pXTC99fEfJ0VJOSkS93HP_fYt7P67gH54ep5PKZ_t8z6OsD3mTfihpeJK6G-Pd3r5TG8_LdVSP_AX5QqgBg
CitedBy_id crossref_primary_10_1186_s12903_023_03488_9
crossref_primary_10_1111_odi_13544
crossref_primary_10_14450_2318_9312_v29_e4_a2017_pp284_301
crossref_primary_10_1007_s12032_022_01673_4
crossref_primary_10_1016_j_hermed_2015_04_005
crossref_primary_10_14260_jemds_2015_1959
crossref_primary_10_1016_j_oooo_2016_02_020
crossref_primary_10_3390_ma14123374
crossref_primary_10_3390_jpm12081272
crossref_primary_10_12998_wjcc_v2_i12_866
crossref_primary_10_5812_ijhrba_11358
crossref_primary_10_1002_hed_24249
crossref_primary_10_1111_jop_12463
crossref_primary_10_4103_ijc_IJC_128_21
crossref_primary_10_1590_1807_2577_02018
crossref_primary_10_1016_j_jormas_2023_101423
crossref_primary_10_1016_j_oooo_2016_07_023
crossref_primary_10_1111_jop_12789
crossref_primary_10_20473_j_djmkg_v53_i3_p115_121
crossref_primary_10_36106_ijsr_7128875
crossref_primary_10_1111_odi_14901
crossref_primary_10_1002_14651858_CD007156_pub3
crossref_primary_10_5005_jp_journals_10024_1406
crossref_primary_10_1016_S0011_8524_14_70161_8
crossref_primary_10_5005_jp_journals_10024_1806
crossref_primary_10_3390_antiox11050868
crossref_primary_10_1016_j_jobcr_2014_12_005
crossref_primary_10_1016_j_biopha_2016_09_096
crossref_primary_10_36106_ijsr_2410759
crossref_primary_10_14260_jemds_2021_246
crossref_primary_10_1111_prd_12277
crossref_primary_10_1016_j_jobcr_2020_08_004
crossref_primary_10_1111_jicd_12208
crossref_primary_10_5005_jp_journals_10057_0224
crossref_primary_10_1002_ptr_7202
crossref_primary_10_7759_cureus_47259
crossref_primary_10_1586_14737140_2013_842898
crossref_primary_10_1586_14737140_2014_842898
crossref_primary_10_1111_jop_13503
crossref_primary_10_3390_plants10102148
Cites_doi 10.1007/BF02992043
10.4103/0970-9290.29865
10.1007/BF02872409
10.1002/1097-0142(19861215)58:12<2628::AID-CNCR2820581214>3.0.CO;2-Z
10.1111/j.1600-0714.1998.tb01915.x
10.1080/15376510309825
10.1016/0278-2391(88)90043-2
10.4103/0970-4388.26022
10.1016/j.tripleo.2006.07.011
10.1111/j.1601-0825.2011.01791.x
10.1111/j.1601-0825.2006.01313.x
10.1111/j.1600-0714.2007.00582.x
10.1038/bjc.1986.20
10.1016/S0901-5027(87)80064-4
10.1016/0030-4220(66)90367-7
10.1111/j.1600-0714.1990.tb00804.x
10.1016/0278-2391(91)90002-4
10.1034/j.1600-0714.2001.300103.x
10.3109/00016481003782041
10.5005/jp-journals-10011-1021
10.1034/j.1600-0714.2001.301007.x
10.1034/j.1600-0714.2000.290601.x
10.1111/j.1600-0714.2008.00696.x
10.1111/j.1600-0528.1985.tb00468.x
10.1016/S0901-5027(87)80055-3
10.1016/S0901-5027(05)80473-4
10.1111/j.1399-0039.1985.tb00946.x
10.1016/S0304-3835(97)00205-X
10.1007/BF02992406
10.1093/ajcp/81.5.623
ContentType Journal Article
Copyright 2012 John Wiley & Sons A/S
2015 INIST-CNRS
2012 John Wiley & Sons A/S.
Copyright_xml – notice: 2012 John Wiley & Sons A/S
– notice: 2015 INIST-CNRS
– notice: 2012 John Wiley & Sons A/S.
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1111/j.1600-0714.2012.01168.x
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-0714
EndPage 761
ExternalDocumentID 10_1111_j_1600_0714_2012_01168_x
22650317
26581304
JOP1168
ark_67375_WNG_DP1FBD7D_J
Genre article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CWXXS
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UDS
V8K
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WRC
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAJUZ
AAUGY
AAVGM
ABCVL
ABHUG
ABPTK
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
AKALU
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4378-c95202862dd9c538a5ef2ec4de8cfbb18e3322561bd7fc32ad48eecff76de2533
IEDL.DBID 33P
ISSN 0904-2512
IngestDate Sat Aug 17 00:49:08 EDT 2024
Fri Nov 22 00:39:08 EST 2024
Sat Sep 28 07:50:36 EDT 2024
Sun Oct 22 16:07:35 EDT 2023
Sat Aug 24 01:04:23 EDT 2024
Wed Oct 30 09:55:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords oral submucous fibrosis
Treatment
Stomatology
antioxidants
Fibrosis
Oral administration
aloe vera
ENT
Antioxidant
Language English
License CC BY 4.0
2012 John Wiley & Sons A/S.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4378-c95202862dd9c538a5ef2ec4de8cfbb18e3322561bd7fc32ad48eecff76de2533
Notes istex:53A03AFB1A1FA3CB0F37710E2BF21A2141093084
ark:/67375/WNG-DP1FBD7D-J
ArticleID:JOP1168
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
PMID 22650317
PQID 1139624592
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1139624592
crossref_primary_10_1111_j_1600_0714_2012_01168_x
pubmed_primary_22650317
pascalfrancis_primary_26581304
wiley_primary_10_1111_j_1600_0714_2012_01168_x_JOP1168
istex_primary_ark_67375_WNG_DP1FBD7D_J
PublicationCentury 2000
PublicationDate November 2012
PublicationDateYYYYMMDD 2012-11-01
PublicationDate_xml – month: 11
  year: 2012
  text: November 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Frederiksberg
– name: Denmark
PublicationTitle Journal of oral pathology & medicine
PublicationTitleAlternate J Oral Pathol Med
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley
References Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966; 22: 764-9.
Gupta S, Reddi MVR, Harinath BC. Role of oxidative stress and antioxidants in etiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 2004; 19: 138-41.
Rajendran R, Sugathan CK, Remani P, Ankathil R, Vijayakumar T. Cell mediated and humoral immune responses in oral submucous fibrosis. Cancer 1986; 58: 2628.
Kerr AR, Warnakulasuriya S, Mighell AJ, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011; 17: 42-57.
Rajendran R, Raju GK, Nair SM, Balasubramanian G. Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India. Bull WHO 1992; 70: 783-9.
Mathur RM, Jha T. Normal oral flexibility a guideline for OSMF cases. J Indian Dent Assoc 1993; 64: 139-43.
Sharma JK, Gupta AK, Mukhija RD, Nigam P. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987; 16: 695-9.
Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 207-13.
Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985; 13: 340-1.
Haque MF, Meghji S, Nazir R, Harris M. Interferon gamma (IFN-γ) may reverse oral submucous fibrosis. J Oral Pathol Med 2001; 30: 12-21.
Ahmad MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian Soc Pedod Prev Dent 2006; 24: 84-9.
Cox S, Zoellner H. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 2009; 38: 220-6.
Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991; 49: 788-91.
Gupta D, Sharma SC. Oral submucous fibrosis - a new treatment regimen. J Oral Maxillofac Surg 1988; 46: 830-3.
Sinor PN, Gupta PC, Murti PR, et al. A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990; 19: 94-8.
Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001; 30: 618-25.
Prabhu SR, et al. Oral disease in the tropics. Delhi: Oxford University Press, 1993; 417-22.
Gupta DS, Gupta MK, Golhar BL. Oral submucous fibrosis - a clinical study and management by physiofibrolysis (MWD). J Indian Dent Assoc 1980; 52: 375-8.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575-80.
Gupta SC, Yadav YC. "MISI" an etiologic factor in oral submucous fibrosis. Indian J Otolaryngol 1978; 30: 5-6.
Phatak AG. Hypercoagulation and fibrinolysis in oral submucous fibrosis. Am J Clin Pathol 1984; 81: 623-8.
Khanna JN, Andrade NN. Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 1995; 24: 433-9.
Rao B. Oral submucous fibrosis - the Davangere Study. JIAOMR 1993; 4: 11-22.
Davis RN. Biological activity of Aloe Vera. Seifen Oele Fette Wachse 1993; 119: 646-9.
Pal P, Harman D, Sharma P, Verma N. Review: Antioxidant in oral health - Recent Scenario. JIAOMA 2004; 16: 119-28.
Jalouli J, Ibrahim SO, Mehrotra R, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010; 130: 1306-11.
Hastak K, Lubri N, Jakhi SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 1997; 116: 265-9.
Lin HJ, Lin JC. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Dis 2007; 13: 407-13.
Shah N, Sharma PP. Role of chewing and smoking habits in the etiology of OSMF: a case control study. J Oral Pathol Med 1998; 27: 475-9.
Auluck A, Rosin MP, Zhang L, Sumanth KN. Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature. J Can Dent Assoc 2008; 74: 735-40.
Phatak AG. Fibrin producing factor in oral submucous fibrosis. Indian J Orolaryngol 1979; 31: 103-4.
Das AD, Balan A, Sreelatha KT. Comparative Study of the Efficacy of Curcumin and Turmeric Oil as Chemopreventive Agents in Oral Submucous Fibrosis: a Clinical and Histopathological Evaluation. JIAOMR 2010; 22: 88-92.
Sinha SN, Jain PK. Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 1979; 31: 72-5.
Canniff JP, Batchelor JR, Dodi IA, Harvey W. HLA-typing in oral submucous fibrosis. Tissue Antigens 1985; 26: 138-42.
Ipe V, Rajendran R, Sugathan CK, Vijayakumar T. Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India. Indian J Cancer 1986; 23: 101-4.
Adhvaryu SG, Bhatt RG, Dayal PK, et al. SCE frequencies in lymphocytes of tobaccobetel nut chewers and patients with oral submucous fibrosis. Br J Cancer 1986; 53: 141-3.
Subapriya R, Kumaraguruparan R, Nagini S, Thangavelu A. Oxidant-antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods 2003; 13: 77-81.
Dorle RM, Jagtap MW. Estimation of complement C3 in oral submucous fibrosis. Int J Oral Maxillofac Surg 1987; 16: 753-6.
Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 2006; 17: 190-8.
Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 2000; 29: 241-8.
1998; 27
2007; 103
1997; 116
2000; 29
1984; 81
1986; 53
1978; 30
1990; 19
2006; 17
1993; 64
1986; 58
2003; 13
1993
2008; 74
1979; 31
2011; 17
1985; 26
2007; 13
2007; 36
1993; 4
1987; 16
2010; 22
1992; 70
1991; 49
1993; 119
2006; 24
2004; 19
1980; 52
2004; 16
1986; 23
1995; 24
2010; 130
1988; 46
1966; 22
2009; 38
2001; 30
1985; 13
Pal P (e_1_2_6_37_2) 2004; 16
Rajendran R (e_1_2_6_21_2) 1992; 70
e_1_2_6_31_2
e_1_2_6_30_2
Prabhu SR (e_1_2_6_13_2) 1993
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_35_2
Davis RN (e_1_2_6_40_2) 1993; 119
Phatak AG (e_1_2_6_10_2) 1979; 31
e_1_2_6_33_2
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_36_2
Ipe V (e_1_2_6_20_2) 1986; 23
e_1_2_6_41_2
Sinha SN (e_1_2_6_39_2) 1979; 31
Mathur RM (e_1_2_6_8_2) 1993; 64
Gupta SC (e_1_2_6_12_2) 1978; 30
e_1_2_6_7_2
Gupta DS (e_1_2_6_34_2) 1980; 52
Auluck A (e_1_2_6_4_2) 2008; 74
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_3_2
e_1_2_6_6_2
Rao B (e_1_2_6_32_2) 1993; 4
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – volume: 22
  start-page: 764
  year: 1966
  end-page: 9
  article-title: Oral submucous fibrosis
  publication-title: Oral Surg Oral Med Oral Pathol
– volume: 13
  start-page: 340
  year: 1985
  end-page: 1
  article-title: Malignant transformation rate in oral submucous fibrosis over a 17‐year period
  publication-title: Community Dent Oral Epidemiol
– volume: 116
  start-page: 265
  year: 1997
  end-page: 9
  article-title: Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis
  publication-title: Cancer Lett
– volume: 53
  start-page: 141
  year: 1986
  end-page: 3
  article-title: SCE frequencies in lymphocytes of tobaccobetel nut chewers and patients with oral submucous fibrosis
  publication-title: Br J Cancer
– volume: 30
  start-page: 618
  year: 2001
  end-page: 25
  article-title: Oral administration from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis
  publication-title: J Oral Pathol Med
– volume: 26
  start-page: 138
  year: 1985
  end-page: 42
  article-title: HLA‐typing in oral submucous fibrosis
  publication-title: Tissue Antigens
– volume: 30
  start-page: 5
  year: 1978
  end-page: 6
  article-title: “MISI” an etiologic factor in oral submucous fibrosis
  publication-title: Indian J Otolaryngol
– volume: 64
  start-page: 139
  year: 1993
  end-page: 43
  article-title: Normal oral flexibility a guideline for OSMF cases
  publication-title: J Indian Dent Assoc
– volume: 49
  start-page: 788
  year: 1991
  end-page: 91
  article-title: Management of oral submucous fibrosis: a conservative approach
  publication-title: J Oral Maxillofac Surg
– volume: 27
  start-page: 475
  year: 1998
  end-page: 9
  article-title: Role of chewing and smoking habits in the etiology of OSMF: a case control study
  publication-title: J Oral Pathol Med
– volume: 36
  start-page: 575
  year: 2007
  end-page: 80
  article-title: Nomenclature and classification of potentially malignant disorders of the oral mucosa
  publication-title: J Oral Pathol Med
– volume: 19
  start-page: 138
  year: 2004
  end-page: 41
  article-title: Role of oxidative stress and antioxidants in etiopathogenesis and management of oral submucous fibrosis
  publication-title: Indian J Clin Biochem
– volume: 119
  start-page: 646
  year: 1993
  end-page: 9
  article-title: Biological activity of Aloe Vera
  publication-title: Seifen Oele Fette Wachse
– start-page: 417
  year: 1993
  end-page: 22
– volume: 130
  start-page: 1306
  year: 2010
  end-page: 11
  article-title: Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India
  publication-title: Acta Otolaryngol
– volume: 70
  start-page: 783
  year: 1992
  end-page: 9
  article-title: Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India
  publication-title: Bull WHO
– volume: 23
  start-page: 101
  year: 1986
  end-page: 4
  article-title: Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India
  publication-title: Indian J Cancer
– volume: 52
  start-page: 375
  year: 1980
  end-page: 8
  article-title: Oral submucous fibrosis – a clinical study and management by physiofibrolysis (MWD)
  publication-title: J Indian Dent Assoc
– volume: 24
  start-page: 433
  year: 1995
  end-page: 9
  article-title: Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases
  publication-title: Int J Oral Maxillofac Surg
– volume: 13
  start-page: 77
  year: 2003
  end-page: 81
  article-title: Oxidant‐antioxidant status in oral precancer and oral cancer patients
  publication-title: Toxicol Mech Methods
– volume: 16
  start-page: 753
  year: 1987
  end-page: 6
  article-title: Estimation of complement C3 in oral submucous fibrosis
  publication-title: Int J Oral Maxillofac Surg
– volume: 29
  start-page: 241
  year: 2000
  end-page: 8
  article-title: Raised tissue copper levels in oral submucous fibrosis
  publication-title: J Oral Pathol Med
– volume: 16
  start-page: 695
  year: 1987
  end-page: 9
  article-title: Clinical experience with the use of peripheral vasodilator in oral disorders
  publication-title: Int J Oral Maxillofac Surg
– volume: 19
  start-page: 94
  year: 1990
  end-page: 8
  article-title: A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut
  publication-title: J Oral Pathol Med
– volume: 58
  start-page: 2628
  year: 1986
  article-title: Cell mediated and humoral immune responses in oral submucous fibrosis
  publication-title: Cancer
– volume: 31
  start-page: 103
  year: 1979
  end-page: 4
  article-title: Fibrin producing factor in oral submucous fibrosis
  publication-title: Indian J Orolaryngol
– volume: 16
  start-page: 119
  year: 2004
  end-page: 28
  article-title: Review: Antioxidant in oral health – Recent Scenario
  publication-title: JIAOMA
– volume: 103
  start-page: 207
  year: 2007
  end-page: 13
  article-title: Efficacy of lycopene in the management of oral submucous fibrosis
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 81
  start-page: 623
  year: 1984
  end-page: 8
  article-title: Hypercoagulation and fibrinolysis in oral submucous fibrosis
  publication-title: Am J Clin Pathol
– volume: 31
  start-page: 72
  year: 1979
  end-page: 5
  article-title: Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis
  publication-title: Indian J Otolaryngol
– volume: 22
  start-page: 88
  year: 2010
  end-page: 92
  article-title: Comparative Study of the Efficacy of Curcumin and Turmeric Oil as Chemopreventive Agents in Oral Submucous Fibrosis: a Clinical and Histopathological Evaluation
  publication-title: JIAOMR
– volume: 30
  start-page: 12
  year: 2001
  end-page: 21
  article-title: Interferon gamma (IFN‐γ) may reverse oral submucous fibrosis
  publication-title: J Oral Pathol Med
– volume: 13
  start-page: 407
  year: 2007
  end-page: 13
  article-title: Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function
  publication-title: Oral Dis
– volume: 74
  start-page: 735
  year: 2008
  end-page: 40
  article-title: Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature
  publication-title: J Can Dent Assoc
– volume: 17
  start-page: 190
  year: 2006
  end-page: 8
  article-title: Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis
  publication-title: Indian J Dent Res
– volume: 24
  start-page: 84
  year: 2006
  end-page: 9
  article-title: Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India
  publication-title: J Indian Soc Pedod Prev Dent
– volume: 4
  start-page: 11
  year: 1993
  end-page: 22
  article-title: Oral submucous fibrosis – the Davangere Study
  publication-title: JIAOMR
– volume: 38
  start-page: 220
  year: 2009
  end-page: 6
  article-title: Physiotherapeutic treatment improves oral opening in oral submucous fibrosis
  publication-title: J Oral Pathol Med
– volume: 46
  start-page: 830
  year: 1988
  end-page: 3
  article-title: Oral submucous fibrosis – a new treatment regimen
  publication-title: J Oral Maxillofac Surg
– volume: 17
  start-page: 42
  year: 2011
  end-page: 57
  article-title: A systematic review of medical interventions for oral submucous fibrosis and future research opportunities
  publication-title: Oral Dis
– volume: 16
  start-page: 119
  year: 2004
  ident: e_1_2_6_37_2
  article-title: Review: Antioxidant in oral health – Recent Scenario
  publication-title: JIAOMA
  contributor:
    fullname: Pal P
– volume: 30
  start-page: 5
  year: 1978
  ident: e_1_2_6_12_2
  article-title: “MISI” an etiologic factor in oral submucous fibrosis
  publication-title: Indian J Otolaryngol
  doi: 10.1007/BF02992043
  contributor:
    fullname: Gupta SC
– ident: e_1_2_6_28_2
  doi: 10.4103/0970-9290.29865
– ident: e_1_2_6_33_2
  doi: 10.1007/BF02872409
– ident: e_1_2_6_18_2
  doi: 10.1002/1097-0142(19861215)58:12<2628::AID-CNCR2820581214>3.0.CO;2-Z
– ident: e_1_2_6_3_2
  doi: 10.1111/j.1600-0714.1998.tb01915.x
– ident: e_1_2_6_5_2
  doi: 10.1080/15376510309825
– ident: e_1_2_6_23_2
  doi: 10.1016/0278-2391(88)90043-2
– ident: e_1_2_6_11_2
  doi: 10.4103/0970-4388.26022
– ident: e_1_2_6_31_2
  doi: 10.1016/j.tripleo.2006.07.011
– ident: e_1_2_6_41_2
  doi: 10.1111/j.1601-0825.2011.01791.x
– volume: 64
  start-page: 139
  year: 1993
  ident: e_1_2_6_8_2
  article-title: Normal oral flexibility a guideline for OSMF cases
  publication-title: J Indian Dent Assoc
  contributor:
    fullname: Mathur RM
– ident: e_1_2_6_26_2
  doi: 10.1111/j.1601-0825.2006.01313.x
– ident: e_1_2_6_2_2
  doi: 10.1111/j.1600-0714.2007.00582.x
– volume: 74
  start-page: 735
  year: 2008
  ident: e_1_2_6_4_2
  article-title: Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature
  publication-title: J Can Dent Assoc
  contributor:
    fullname: Auluck A
– volume: 31
  start-page: 72
  year: 1979
  ident: e_1_2_6_39_2
  article-title: Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis
  publication-title: Indian J Otolaryngol
  contributor:
    fullname: Sinha SN
– volume: 23
  start-page: 101
  year: 1986
  ident: e_1_2_6_20_2
  article-title: Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India
  publication-title: Indian J Cancer
  contributor:
    fullname: Ipe V
– ident: e_1_2_6_15_2
  doi: 10.1038/bjc.1986.20
– volume: 119
  start-page: 646
  year: 1993
  ident: e_1_2_6_40_2
  article-title: Biological activity of Aloe Vera
  publication-title: Seifen Oele Fette Wachse
  contributor:
    fullname: Davis RN
– ident: e_1_2_6_14_2
  doi: 10.1016/S0901-5027(87)80064-4
– ident: e_1_2_6_9_2
  doi: 10.1016/0030-4220(66)90367-7
– ident: e_1_2_6_36_2
  doi: 10.1111/j.1600-0714.1990.tb00804.x
– volume: 70
  start-page: 783
  year: 1992
  ident: e_1_2_6_21_2
  article-title: Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India
  publication-title: Bull WHO
  contributor:
    fullname: Rajendran R
– ident: e_1_2_6_38_2
  doi: 10.1016/0278-2391(91)90002-4
– ident: e_1_2_6_25_2
  doi: 10.1034/j.1600-0714.2001.300103.x
– volume: 52
  start-page: 375
  year: 1980
  ident: e_1_2_6_34_2
  article-title: Oral submucous fibrosis – a clinical study and management by physiofibrolysis (MWD)
  publication-title: J Indian Dent Assoc
  contributor:
    fullname: Gupta DS
– ident: e_1_2_6_19_2
  doi: 10.3109/00016481003782041
– ident: e_1_2_6_7_2
  doi: 10.5005/jp-journals-10011-1021
– ident: e_1_2_6_29_2
  doi: 10.1034/j.1600-0714.2001.301007.x
– volume: 4
  start-page: 11
  year: 1993
  ident: e_1_2_6_32_2
  article-title: Oral submucous fibrosis – the Davangere Study
  publication-title: JIAOMR
  contributor:
    fullname: Rao B
– ident: e_1_2_6_22_2
  doi: 10.1034/j.1600-0714.2000.290601.x
– ident: e_1_2_6_35_2
  doi: 10.1111/j.1600-0714.2008.00696.x
– ident: e_1_2_6_6_2
  doi: 10.1111/j.1600-0528.1985.tb00468.x
– start-page: 417
  volume-title: Oral disease in the tropics
  year: 1993
  ident: e_1_2_6_13_2
  contributor:
    fullname: Prabhu SR
– ident: e_1_2_6_27_2
  doi: 10.1016/S0901-5027(87)80055-3
– ident: e_1_2_6_24_2
  doi: 10.1016/S0901-5027(05)80473-4
– ident: e_1_2_6_16_2
  doi: 10.1111/j.1399-0039.1985.tb00946.x
– ident: e_1_2_6_30_2
  doi: 10.1016/S0304-3835(97)00205-X
– volume: 31
  start-page: 103
  year: 1979
  ident: e_1_2_6_10_2
  article-title: Fibrin producing factor in oral submucous fibrosis
  publication-title: Indian J Orolaryngol
  doi: 10.1007/BF02992406
  contributor:
    fullname: Phatak AG
– ident: e_1_2_6_17_2
  doi: 10.1093/ajcp/81.5.623
SSID ssj0017341
Score 2.3204808
Snippet J Oral Pathol Med (2012) 41: 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly...
Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The...
J Oral Pathol Med (2012) 41 : 755–761 Background and objectives:  Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly...
BACKGROUND AND OBJECTIVESOral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 755
SubjectTerms Administration, Topical
Adolescent
Adult
Aloe
aloe vera
antioxidants
Antioxidants - therapeutic use
Biological and medical sciences
Dentistry
Female
Gels
Humans
Male
Medical sciences
oral submucous fibrosis
Oral Submucous Fibrosis - drug therapy
Otorhinolaryngology. Stomatology
Phytotherapy - methods
Plant Extracts - therapeutic use
Severity of Illness Index
Treatment Outcome
Young Adult
Title Aloe vera in the treatment for oral submucous fibrosis - a preliminary study
URI https://api.istex.fr/ark:/67375/WNG-DP1FBD7D-J/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0714.2012.01168.x
https://www.ncbi.nlm.nih.gov/pubmed/22650317
https://search.proquest.com/docview/1139624592
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BOcClvNtQqIyEuAXVjzjOsTRd0B6WlQDBzXJsR6qg2WrDSj3yH_iH_BJmnG4gUg8IcYsiTTSZ8cx8tucB8EJWLratFznGKpOrgBgOQazOg9SR2q052aQhtu_LxWdTn1KbnPm2FmboDzEeuJFlJH9NBu6afmrkmqqiS05HI3Skx7k2rwhP4qYhVXPI5XihUMo0xPKoOlI5hfRpUs-1H5pEqlsk9EvKnHQ9Cq8dpl5cB0unKDeFqdnd__mD92D3Cqyy42F13YcbsXsAt2tKMKIZcQ9hcfx1FRlag2NnHUMsycbEdYZomFH5P-uR4Y1fbXrWIj-r_qxnP7__YI5drJHD81QQzFKb20fwcXb64eRtfjWhIfdK4vbTV4VAgKJFCJVH1-mK2IroVYjGt03DTZTkMDRvQtl6KVxQJkbftqUOUSDSfAw73aqL-8AQpprAeTC6Cko10jQG14lwvtBOcBkz4Ftt2IuhEYf9YwODkrIkKUuSsklS9jKDl0ltI4Fbf6FEtrKwnxZvbL3ks9d1Wdt5BocTvY4EAgEaRnmVwfOtoi3aH12quC6i5JABWWmhikpksDesgN_USI5Os8xAJ0X_NeN2_m5JT0_-lfAA7tDroWjyKex8W2_iM7jZh81hsotftw0Inw
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BeygX3pTwKEZC3ILqxzrOsZAupS3LShTBzXJsR6qAbLVhpR75D_xDfgkzTjcQqQeEuOWQiSbz8Hy25wHwTJYuNo0XOcYqk6uAGA5BrM6D1JHarTlZpyG274vZJ1PtU5uco3UtTN8fYjhwI89I6zU5OB1Ij71cU1l0welshM70ONfmBQLKTaXRLqmeQ86HK4VCpjGWu-Wuyimoj9N6Lv3SKFZtktjPKXfSdSi-pp97cRkwHePcFKimN_7rL96E6xd4le31BnYLrsT2NmxVlGNEY-LuwGzvyyIydAjHTluGcJINuesMATGjDgCsQ45XfrHqWIMMLbrTjv38_oM5drZEFr-mmmCWOt3ehQ_T_ZNXB_nFkIbcK4k7UF9OBGIULUIoPa6ebhIbEb0K0fimrrmJktYMzetQNF4KF5SJ0TdNoUMUCDbvwUa7aON9YIhUTeA8GF0GpWppaoOmIpyfaCe4jBnwtTrsWd-Lw_6xh0FJWZKUJUnZJCl7nsHzpLeBwC0_Uy5bMbEfZ69tNefTl1VR2cMMdkaKHQgEYjQM9CqDp2tNW3RBuldxbUTJIQOy1EJNSpHBdm8Cv6mRHNfNIgOdNP3XjNvDd3N6evCvhE9g6-Dk7bE9fjM7egjX6JW-hvIRbHxbruJjuNqF1U5ykl9_mQzH
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaglaAX3oXwKEZC3ILqRxznWEgXWNCyEq3gZjl-SFVpdrVhpR75D_xDfgkzTjcQqQeEuOWQiSYznpnP9jwIeS4qG2J0PIdYpXPpAcMBiFW5FypguzUrmjTE9lM5-6LrQ2yTM93UwvT9IYYDN7SM5K_RwJc-jo1cYVV0yfBoBI_0GFP6JeDJbQmoHPvoCzEfbhRKkaZY7lf7MseYPs7qufRLo1C1jVI_x9RJ24H0Yj_24jJcOoa5KU5Nbv7PP7xFblygVXrQL6_b5Epo75DrNWYY4ZC4u2R28HURKJiDpSctBTBJh8x1CnCYYv0_7YDhtVusOxqBn0V30tGf339QS5cr4PAsVQTT1Of2HjmeHB69fptfjGjInRSw_3RVwQGhKO595cB32iJEHpz0QbvYNEwHgR5DscaX0QluvdQhuBhL5QMHqLlLttpFGx4QCjhVe8a8VpWXshG60bBQuHWFspyJkBG20YZZ9p04zB87GJCUQUkZlJRJkjLnGXmR1DYQ2NUpZrKVhfk8e2PqOZu8qsvaTDOyN9LrQMABoUGYlxl5tlG0AQPEWxXbBpAcMCAqxWVR8Yzc71fAb2ogB69ZZkQlRf8142b6cY5PD_-V8Cm5Nq8n5sO72ftHZAff6AsoH5Otb6t1eEKudn69l0zkFxxrC20
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aloe+vera+in+the+treatment+for+oral+submucous+fibrosis+%E2%80%93+a+preliminary+study&rft.jtitle=Journal+of+oral+pathology+%26+medicine&rft.au=Sudarshan%2C+Ramachandran&rft.au=Annigeri%2C+Rajeshwari+G.&rft.au=Sree+Vijayabala%2C+G.&rft.date=2012-11-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0904-2512&rft.eissn=1600-0714&rft.volume=41&rft.issue=10&rft.spage=755&rft.epage=761&rft_id=info:doi/10.1111%2Fj.1600-0714.2012.01168.x&rft.externalDBID=10.1111%252Fj.1600-0714.2012.01168.x&rft.externalDocID=JOP1168
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0904-2512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0904-2512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0904-2512&client=summon